Stock Track | Smith & Nephew PLC Plummet 6.25% in pre-market after cutting revenue guidance and missing Q2 sales estimates

Stock Track08-04

Smith & Nephew PLC (SNN) shares plummeted 6.25% in pre-market trading Tuesday, following the company's release of its fiscal second-quarter results and a downward revision to its full-year revenue outlook.

The medical-technology company reported Q2 revenue of $1.6 billion, up from $1.55 billion a year earlier, but fell short of the $1.63 billion consensus estimate. Consequently, Smith & Nephew lowered its 2026 underlying revenue growth guidance to about 4%, down from its previous forecast of around 6%. The company cited weakness in its U.S. orthopedics segment, particularly in hip and knee implants, as well as challenges in its advanced wound management division due to changes in U.S. reimbursement rules for skin substitutes.

CEO Deepak Nath noted that orthopedics is not where the company wants it to be, but expects growth to accelerate as portfolio gaps are filled later this year and into 2027. The guidance cut and revenue miss triggered a sharp sell-off, dominating the pre-market session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100133142?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-04 21:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100133142","market":"nz","top_or_hot":-1,"title":"Stock Track | Smith & Nephew PLC Plummet 6.25% in pre-market after cutting revenue guidance and missing Q2 sales estimates","media":"Stock Track","content":"<p>Smith & Nephew PLC (SNN) shares plummeted 6.25% in pre-market trading Tuesday, following the company's release of its fiscal second-quarter results and a downward revision to its full-year revenue outlook.</p><p>The medical-technology company reported Q2 revenue of $1.6 billion, up from $1.55 billion a year earlier, but fell short of the $1.63 billion consensus estimate. Consequently, Smith & Nephew lowered its 2026 underlying revenue growth guidance to about 4%, down from its previous forecast of around 6%. The company cited weakness in its U.S. orthopedics segment, particularly in hip and knee implants, as well as challenges in its advanced wound management division due to changes in U.S. reimbursement rules for skin substitutes.</p><p>CEO Deepak Nath noted that orthopedics is not where the company wants it to be, but expects growth to accelerate as portfolio gaps are filled later this year and into 2027. The guidance cut and revenue miss triggered a sharp sell-off, dominating the pre-market session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Smith & Nephew PLC Plummet 6.25% in pre-market after cutting revenue guidance and missing Q2 sales estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Smith & Nephew PLC Plummet 6.25% in pre-market after cutting revenue guidance and missing Q2 sales estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-08-04 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Smith & Nephew PLC (SNN) shares plummeted 6.25% in pre-market trading Tuesday, following the company's release of its fiscal second-quarter results and a downward revision to its full-year revenue outlook.</p><p>The medical-technology company reported Q2 revenue of $1.6 billion, up from $1.55 billion a year earlier, but fell short of the $1.63 billion consensus estimate. Consequently, Smith & Nephew lowered its 2026 underlying revenue growth guidance to about 4%, down from its previous forecast of around 6%. The company cited weakness in its U.S. orthopedics segment, particularly in hip and knee implants, as well as challenges in its advanced wound management division due to changes in U.S. reimbursement rules for skin substitutes.</p><p>CEO Deepak Nath noted that orthopedics is not where the company wants it to be, but expects growth to accelerate as portfolio gaps are filled later this year and into 2027. The guidance cut and revenue miss triggered a sharp sell-off, dominating the pre-market session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNN","symbol_name":"Smith & Nephew PLC ADS","start_time":0,"source_url":"","article_id":"1100133142","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100133142","pubTimestamp":1785851283,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Smith & Nephew PLC (SNN) shares plummeted 6.25% in pre-market trading Tuesday, following the company's release of its fiscal second-quarter results and a downward revision to its full-year revenue...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SNN":"Smith & Nephew PLC ADS"},"translate_title":"股票跟踪 | Smith & Nephew PLC 在下调收入指引并未达到第二季度销售预期后，盘前股价暴跌 6.25%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNN":1},"content_text":"Smith & Nephew PLC (SNN) shares plummeted 6.25% in pre-market trading Tuesday, following the company's release of its fiscal second-quarter results and a downward revision to its full-year revenue outlook.The medical-technology company reported Q2 revenue of $1.6 billion, up from $1.55 billion a year earlier, but fell short of the $1.63 billion consensus estimate. Consequently, Smith & Nephew lowered its 2026 underlying revenue growth guidance to about 4%, down from its previous forecast of around 6%. The company cited weakness in its U.S. orthopedics segment, particularly in hip and knee implants, as well as challenges in its advanced wound management division due to changes in U.S. reimbursement rules for skin substitutes.CEO Deepak Nath noted that orthopedics is not where the company wants it to be, but expects growth to accelerate as portfolio gaps are filled later this year and into 2027. The guidance cut and revenue miss triggered a sharp sell-off, dominating the pre-market session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100133142","isCrawlerRequest":true}